This mechanism of action is more aligned with the bodys natural processes, making it a more sustainable option for weight loss. 11 Myth : Using compounded GLP-1 drugs is just as safe as using brand-name GLP-1 medicines
And with employer-sponsored health costs expected to reach their highest point in a decade in 2025 due in part to coverage of pricey drugs such as GLP-1s businesses are grappling with how to manage costs while meeting employee needs
Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years
Gregg EW, Hora I, Benoit SR (2019) Resurgence in diabetes-related complications
Malm-Erjeflt M, Bjrnsdottir I, Vanggaard J, Helleberg H, Larsen U, Oosterhuis B, et al